are heterodlmenc cell surface receptors that mediate a cell's ability to perceive its environment, respond to changed m its environment, and alter its environment When activated, these receptors form focal adhesions, which are areas of close attachment of the cells to extracellular matnx proteins m which colocahzatlon of cytoskeletal protems, intracellular slgnalmg molecules, and growth factor receptors occurs In cardiac fibroblasts, mtegnns mediate cell growth and adhesion Growth factors such as angotensm II regulate DNA synthesis, protooncogene expression, extracellular matrix production, adhesion, and other actions of cardiac fibroblasts, many ofwhlch reqmre mtegrm activation In addition to controllmg growth factor and hemodynamlc effects, regulation of mtegnn activity may be useful to affect cardiac fibrosis and the remodeling process (Hypertension. 1998;31[part 2]:176-180.) Key Words: mtegrms n extracellular matnx n cardiac fibroblasts w angotensm II w fibrosis I ntegrms are a family of a transmembrane receptors that mediate a vanety of cell functions including adhesion, growth, and motlhty They are composed of (Y and p subunit heterodlmers that consist of a large extracellular domain, a transmembrane regon, and a relatively short cytoplasrmc domain I-3 The extracellular domain binds to proteins that form the ECM such as fibronectm, collagen, vltronectm, osteopontm, and others, while the cytoplasmlc domains mteract with cytoskeletal proteins and intracellular signaling molecules Thus, mtegnns have a unique role, transmitting mformatlon from the external environment of the cell that then influences structural changes within the cell and thus ultimately regulates cell activity The engagement of mtegnns by certain ECM proteins nntlates the locahzatlon of cytoskeletal proteins into focal adhesions, which are areas of tight assoclatlon between the plasma membrane and the ECM 4 Focal adhesions represent the colocallzatlon of cytoskeletal protems such as tahn and cw-actmm, FAK, mtegnns, growth factor receptors, and other signaling molecules ' 56 In general, this colocahzatlon 1s dependent on the mtegnn P-cytoplasnuc domain, which 1s highly conserved between species and for each of the j3 subtypes ' Signaling molecules such as C-X, FAK, phosphotldyhnosltol 3 kmase, phosphohpase C6, MAPK, MEK, JNK, Ras, Raf, and others are associated with focal adhesions 5 ' The colocahzatlon of all these molecules 1s likely an important means of faclhtatmg their mteractlons
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In addition to the presence of growth factor receptors, growth factor receptor substrates are also present m focal adhesions For example, the msuhn receptor substrate 1 that 1s phosphorylated m response to tyrosme phosphorylatlon of the insulin receptor associates with the mtegnn CX, p3 on actlvatlon of the msuhn receptor '
The attachment and spreading of cells are functionally important for their growth, survival, and motlhty Prevention of attachment leads to cell death 9 Actlvatlon of mtegrms can induce protooncogene expression and regulate the productlon of cell cycle proteins '" " Current data suggest that mtegnns may act at two points m the cell cycle regulation of the GO/G1 transition and Gl/S transmon I2 I3 Integnns may also affect the apoptotlc process I4 The tyrosme kmase, FAK, 1s phosphorylated m vanous cells when the cells are attached to fibronectm, lammm, vltronectm, collagen, and other ECM protems " l6 Activation requires mtegnty of the actm cytoskeleton and an intact /3-cytoplasmlc domain " Four tyrosme sites m FAK can be phosphorylated, phosphorylatlon of specific sites can actlvate certain signaling pathways '* FAK appears to be an important regulator m the movement of cells, since cells that are deficient m FAK have reduced monhty m vitro, while overexpresslon of FAK 1s associated with increased motlhty "I 'I' FAK 1s not only activated by mtegrms, since growth factors such as endothelm, angotensm II, vasopressm, and others can stimulate phosphorylatlon of FAK 21z22 While ECM proteins can influence mtegnn activity, mtegnn actlvatlon can m turn regulate components of the ECM For example, collagen and fibronectm, through their bmdmg to mtegnns, can induce the expression of metalloprotemases, collagenase, gelatmase, and other enzymes that regulate the amount and type of protein m the ECM *' The cellular response 1s dictated by which ECM protein activates which specific mtegnn In addition, actlvatlon of mtegnns affects the Inflammatory response through regulation of NF-KB actlvlty, which itself can control mtegnn-mediated gene expresslon 24 Increasing evidence suggests that mtegnns play an important role m cardiovascular remodeling
Integrms that bind to the RGD motif, such as CX, p3 and others, are important m the angiogenic process 25 Inhlbltors of these mtegnns inhibit angogenesis and may hmlt tumor growth by thus hmltmg their of a~$3 and p5 in the rat cardiac fibroblact, but httle efiect of AI1 was seen on these mtegrm meTsage levels 117 human cardiac fibroblasts (Hsueh WA, Do YS, unpubhshed obrervationc). (~$3 binds to a variety of RGD-contamng ligands such as fibronectm, thrornbm, fibrinogen, collagen, thrombospondm, and others, vvlnle /31 more commonly bind7 to collagen and a$5 to vitronectm." Actlvatlon of a$3 by fibronectm or /31 by collagen enhances MAP kmase activity m rat cardiac fibroblasts. Furthermore, adheFlon to collagen or fibronectm Increases the stnnulatlon of MAP kmase actwty by AI1 and enhances the effect of AI1 to induce protooncogene expression (Hsueh WA, Do YS, unpublished observations). Thus, ECM proteins work in conjunction with growth factors such as AI1 to stimulate intracellular signaling pathways that promote growth in the cardiac fibroblast, a feature suggesting that the ECM plays a dynamic rather than a passive role in the cardiac remodeling process.
OP is a large acidic phosphoprotein that contains calcium binding doniains and a RGD niotif that contributes to adhesion, growth, and motility in vascular smooth muscle cells."" OP levels are increased in calcified atherosclerotic plaques. This protein is present in low quantities in normal adult'rat and human heart, but OP message and protein are readily detectable in neonatal or hypertrophied adult rat heart and in hypertrophied human heart."' AI1 is a potent stimulator of OP production on cultured rat cardiac fibroblasts; TGF-/3 and PDGF can also enhance OP production in these cells.45 Human cardiac fibroblasts, however, contain low levels of OP that do not respond to treatment of cells with AI1 or PDGF. Immunohistochemical studies and in situ hybridization indicate that cardiomyocytes in hypertrophied rat and human heart are a major source of OP in the heart, and in hypertrophied rat heart, OP message levels correlate with ANP message levels.*" ET and NE, but not AII, stimulate OP production in cultured rat cardionlyocytes.2" Antibodies to OP inhibit AII-induced cardiac fibroblast growth (Fig 1) and the ability of cardiac fibroblasts to adhere to and contract collagen gels (Fig 2) . Antibodies against ~~$33 and pl also inhibit these functions of cardiac fibroblasts.'" Thus, OP interacting with ~~743 and possibly avpl that bind to RGD sequences on OP mediates AI1 growth effects and collagen contraction, which in the skin is the last important step in wound healing."' The effects of OP and the role of integrins in cardiomyocytes has yet to be determined; OP appears to be a paracrine means by which growing or hypertrophied myocytes influence fibroblast growth and other behaviors that are intimately involved in the development of cardiac fibrosis.
The relationship between the effect of growth factors and the ECM is summarized in Fig 3. ET from endothelial cells and the endocardium and NE from cardiac nerve endings stimulate myocyte hypertrophy.
AI1 has a modest direct effect on myocytes but stimulates both ET, and NE production. AII, PDGF, FGF, and EGF stimulate myofibroblast growth; AI1 can also enhance ET production in the myofibroblast that promotes myocyte hypertrophy and TGF-P production that mediates ECM biosynthesis." The ECM provides the external milieu for the myofibroblast to control growth and adhesion. OP is secreted from the myocyte, particularly in the hypertrophic state, and from the myofibroblast in response to growth factors (AU) and mediates growth and adhesion of the myofibroblast. The ECM also affects myocyte contractility, oxygenation, and likely its hypertrophic responses. Integrins are mtimately involved in medlatmg OP and ECM effects and synerglze with growth factor effects through focal adhesions. An important question 1s when and how to control the cardiac remodeling response. Myocyte hypertrophy and cardiac fibrosis are both potentially reversible."" Decreasing the workload is critically important. Lowering blood pressure induces regression of LVH.J7,4X Afterload reduction in heart failure improves cardiac performance.47'X In end-stage heart failure, left ventricular assist devices decrease the high levels of ANP produced by the stressed myocyte,"" and in patients who are placed on these devices, the improved cardiac function that results may be permanent.'"~s' Local factors that are produced in the heart, such as ANP and NO, impair cell growth and ECM production and serve as a natural mechanism to balance the local effects of growth factors and vasoconstrictors."2 Whether enhancing the production of these counterbalancing factors (eg, ACE1 increase tissue production of bradykinin that stimulates NO) is useful in the heart remains to be determined. Inhibition of AI1 production by ACE1 or its action by AT, receptor blockade induces regresclon of hypertrophy m hypertension by mechanisms that appear to extend beyond blood pressure-lowering effects.47,48 In post-myocardial infarction models, timing of control of fibrosis is critical, since wound healing after the acute event is necessary. However, continuation of the wound-healing process leads to progressive hypertrophy, dilation, and fibrosis of the ventricular wall, even in the noninfarcted segments, leading to globular heart fibrosis and failure.47~'x Inhibition of the renin-angiotensin system mipalrs this post-myocardlal Infarction respome, improves cardiac function, and importantly decreases mortality."~" Several other potential approaches exist to control fibrosis: regulate TGF-P activity, control enzymes such as metalloproteinases that degrade fibrillar collagen and matrix, inhibit integrin receptors or OP, control signaling and nuclear pathways that regulate matrix production, and others. Further investigation will be necessary to characterize the fibrotic process in different models of cardiac remodeling and to define the molecular, cellular, biochemical, and mechamcal factors mvolved to identify the most usefLl1 and safest approaches to regulate ventricular wall composition, structure, and, ultimately, function. 
